glp-1 athletes Serena, Simone… and Tom Brady: Star are now promoting GLP-1s — what it means for your weight loss Can Microdosing GLP 1 Enhance
Description
A meta-analysis of seven placebo-controlled cardiovascular outcomes trials found no increased risk of either acute pancreatitis or pancreatic cancer with GLP-1 RA treatment (Peto OR: 1.05, 95% CI 0.78, 1.40), 70 providing reassurance evidence against this concern in high-risk populations

With applications expanding from diabetes and obesity into cardiovascular disease, longevity and wellness, the commercial opportunity continues to grow, intensifying the competition for strategic assets

Arch Toxicol

This JAMA Patient Page describes early-onset GI cancer and its risk factors, signs and symptoms, management, prognosis, and prevention measures

Qi J, Li M, Wang L, et al
The potential interaction between UCP2 and PPAR was investigated through bioinformatics analysis using the STRING database ( The results suggest an association between the UCP2 and PPAR proteins (Fig
